Features editor of Scrip Intelligence and editor of Scrip 100. All views expressed are my own.
London
Joined May 2012
- Tweets551
- Following205
- Followers552
- Likes27
Jo Shorthouse retweeted
$NVS CEO tells me Cosentyx overtaken Humira in PsA/AS in the USA, had Q1 sales $791m, up 41%, Entresto up 85% to $357m
Jo Shorthouse retweeted
Sydney Brenner: Molecular biology pioneer dies - a giant has left the stage bbc.co.uk/news/science-envir…
Jo Shorthouse retweeted
16% jump in Daiichi Sankyo's share price this morning in Tokyo reflects size, significance of deal #pharma #biotech #cancer #daiichisankyo #astrazeneca
Boost For Daiichi's Oncology Ambitions As AZ Agrees Huge $6.9bn Deal For Lead ADC Asset scrip.pharmaintelligence.inf…
Jo Shorthouse retweeted
What Brexit Effect? UK Biotech Start-Ups Reach Record Numbers
bit.ly/2FhQYsS #PharmaScrip
Peter McNaughton of @KingsCollegeLon talked to me yesterday about the ground breaking science behind a new class of analgesics, #Merck pretty impressed too.
Merck Makes Its Debut In Pain With Pioneering New Analgesic Class
bit.ly/2u5cqw5 #PharmaScrip
Simon Moroney, @MorphoSys CEO stalwart is to retire by middle of next year. He talked to me about his hopes to inspire small EU #biotech and reacts to the Darzalex IP loss.
Building A Biotech: Industry Veteran Moroney Reflects
bit.ly/2tGzQrq #PharmaScrip
Jo Shorthouse retweeted
I am delighted to announce that from October I will be the new Master of @TrinCollCam. It has truly been an honour to be the first female Chief Medical Officer and I will be working relentlessly until I step down at the end of September gov.uk/government/news/profe…
Jo Shorthouse retweeted
Ian Hudson chairing a session at #DIAEurope2019 today. This year is Hudson’s last appearance at DIA Europe as head of @MHRAgovuk. He’s stepping down as chief exec of UK agency in September.
Jo Shorthouse retweeted
Wow. José Baselga, who quit Memorial Sloan Kettering after failing to disclose financial conflicts of interests, to head up R&D oncology at #AstraZeneca
Jo Shorthouse retweeted
When reflecting on the licensing deals inked this year by biotech behemoth @genentech, two really stand out. At #BIOEurope @ScripJo sits down with Don O’Sullivan, the company's Head of Immunology and Infectious Disease Business Development. spr.ly/6019E1Ffx
Jo Shorthouse retweeted
After careful reflection, I will not be supporting the Government on the EU Withdrawal Agreement. As such, I have tended my resignation as Universities & Science Minister – read more on my Facebook page: facebook.com/204388219715107…
Jo Shorthouse retweeted
It's finally here! Time to get those glad rags on and join us tonight at the Hilton, Park Lane for the #ScripAwards2018! We look forward to seeing you tonight!
Jo Shorthouse retweeted
Per Norlen, CEO of @AlligatorBio, tells @PharmaScrip's @ScripJo about the recent addition to the pipeline, and the next big milestones for the company. Watch #BIOEurope interview >> spr.ly/6014EDm74
Jo Shorthouse retweeted
🎥 @ScripJo talks to @RedHillBio COO, Gilead Raday, on the company's novel antibiotic approach to #CrohnsDisease. Watch #BIOEurope interview >> spr.ly/6016EDm4s
Jo Shorthouse retweeted
🎥 @ScripJo to @RedHillBio COO, Gilead Raday, on the company's novel antibiotic approach to #CrohnsDisease. Watch #BIOEurope interview >> spr.ly/6019EDmNd
Jo Shorthouse retweeted
Per Norlen, CEO of @AlligatorBio, tells @PharmaScrip's @ScripJo about the recent addition to the pipeline, and the next big milestones for the company. Watch #BIOEurope interview >> spr.ly/6010EDm7g
Jo Shorthouse retweeted
🎥 @Lundbeck CEO and president Deborah Dunsire talks to @ScripJo about what drew her to the pharma company, which specializes in neurological disorders. Watch #BIOEurope interview >> spr.ly/6010EDm4y
Jo Shorthouse retweeted
1 Week left before the #ScripAwards2018 at the Hilton on Park Lane, London! Join us for an evening of glitz, glam, good food and networking. Last few tables remaining - book yours today! bit.ly/2DMxaiP
